Terms: = Prostate cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB
338 results:
1. cancer incidence and digital information seeking in Germany: a retrospective observational study.
Wecker H; Maier D; Ziehfreund S; Fox FAU; Erhard I; Vehreschild JJ; Zink A
Sci Rep; 2024 May; 14(1):10184. PubMed ID: 38702333
[TBL] [Abstract] [Full Text] [Related]
2. Demographical and Epidemiological Contribution to cancer Incidence in Delhi and Its Trends from 1991-2015.
Malhotra RK; Manoharan N; Deo SS; Bhatnagar S
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1213-1222. PubMed ID: 38679980
[TBL] [Abstract] [Full Text] [Related]
3. Breakthrough electroneutron multi-response miniature dosimetry/spectrometry in medical accelerator.
Sohrabi M; Malekitakbolagh M; Nedaei HA
Sci Rep; 2024 Apr; 14(1):9557. PubMed ID: 38664481
[TBL] [Abstract] [Full Text] [Related]
4. Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation study.
Diamand R; Roche JB; Lacetera V; Simone G; Windisch O; Benamran D; Fourcade A; Fournier G; Fiard G; Ploussard G; Roumeguère T; Peltier A; Albisinni S
World J Urol; 2024 Apr; 42(1):247. PubMed ID: 38647728
[TBL] [Abstract] [Full Text] [Related]
5. Targeting androgen biosynthesis in prostate cancer: implications on endocrine physiology.
Kango G; Malek R; Mannuel H; Hussain A
Curr Opin Oncol; 2024 May; 36(3):195-201. PubMed ID: 38573209
[TBL] [Abstract] [Full Text] [Related]
6. Prediction of false-positive PI-RADS 5 lesions on prostate multiparametric MRI: development and internal validation of a clinical-radiological characteristics based nomogram.
Cheng Y; Fan B; Fu Y; Yin H; Lu J; Li D; Li X; Qiu X; Guo H
BMC Urol; 2024 Apr; 24(1):76. PubMed ID: 38566091
[TBL] [Abstract] [Full Text] [Related]
7. The impact of the relationship between lesion diameter and total core length on the detection rate of clinically significant prostate cancer for PI-RADS 3 lesions.
Yakut E
World J Urol; 2024 Mar; 42(1):162. PubMed ID: 38488892
[TBL] [Abstract] [Full Text] [Related]
8. Annual mpMRI surveillance: PI-RADS upgrading and increasing trend correlated with patients who harbor clinically significant disease.
Greenberg JW; Koller CR; Lightfoot C; Brinkley GJ; Leinwand G; Wang J; Krane LS
Urol Oncol; 2024 May; 42(5):158.e11-158.e16. PubMed ID: 38365461
[TBL] [Abstract] [Full Text] [Related]
9. Statistics of Rare Events.
Proschan MA; Kherabi Y
NEJM Evid; 2024 Jan; 3(1):EVIDe2300303. PubMed ID: 38320520
[TBL] [Abstract] [Full Text] [Related]
10. Targeted Inhibition of CYP11A1 in Castration-Resistant prostate cancer.
Fizazi K; Bernard-Tessier A; Roubaud G; Utriainen T; Barthélémy P; Fléchon A; van der Voet J; Gravis G; Ratta R; Jones R; Parikh O; Tanner M; Antonarakis ES; Baldini C; Peters N; Garratt C; Ikonen T; Pohjanjousi P; Joensuu H; Cook N
NEJM Evid; 2024 Jan; 3(1):EVIDoa2300171. PubMed ID: 38320513
[TBL] [Abstract] [Full Text] [Related]
11. Charcot neuroarthropathy in persons with diabetes: It's time for a paradigm shift in our thinking.
Wukich DK; Frykberg RG; Kavarthapu V
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3754. PubMed ID: 38069459
[TBL] [Abstract] [Full Text] [Related]
12. PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression.
Miller KA; Degan S; Wang Y; Cohen J; Ku SY; Goodrich DW; Gelman IH
Oncogene; 2024 Jan; 43(1):22-34. PubMed ID: 37875657
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of robotic-assisted laparoscopic radical prostatectomy: SP versus XI, a single surgeon experience.
Roy SS; Sathe AA; Watson MJ; Singh A
J Robot Surg; 2023 Dec; 17(6):2817-2821. PubMed ID: 37736871
[TBL] [Abstract] [Full Text] [Related]
14. Ultra-Processed Food Consumption and Mortality: Three Cohort Studies in the United States and United Kingdom.
Zhao Y; Chen W; Li J; Yi J; Song X; Ni Y; Zhu S; Zhang Z; Xia L; Zhang J; Yang S; Ni J; Lu H; Wang Z; Nie S; Liu L
Am J Prev Med; 2024 Feb; 66(2):315-323. PubMed ID: 37690589
[TBL] [Abstract] [Full Text] [Related]
15. Sociocultural factors associated with physical activity in Black prostate cancer survivors.
Buro AW; Carson TL; Small BJ; Fan W; Oswald LB; Jim HSL; Salas E; Zambrano K; Bryant C; Yamoah K; Gwede CK; Park JY; Gonzalez BD
Support Care Cancer; 2023 Jul; 31(8):482. PubMed ID: 37479918
[TBL] [Abstract] [Full Text] [Related]
16. A novel strategy for the study on molecular mechanism of prostate injury induced by 4,4'-sulfonyldiphenol based on network toxicology analysis.
Huang S
J Appl Toxicol; 2024 Jan; 44(1):28-40. PubMed ID: 37340727
[TBL] [Abstract] [Full Text] [Related]
17. The utility of the [-2]pro-prostate-specific antigen level as a prognostic marker in patients with castration-resistant prostate cancer treated with enzalutamide.
Miyazawa Y; Hori K; Tsuji Y; Sekine Y; Arai S; Fujizuka Y; Nomura M; Koike H; Matsui H; Suzuki K
Int J Urol; 2023 Oct; 30(10):839-846. PubMed ID: 37256915
[TBL] [Abstract] [Full Text] [Related]
18. Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review.
Yonese J; Hinata N; Masui S; Nakai Y; Shirotake S; Takeuchi A; Inamoto T; Nozawa M; Ueda K; Etsunaga T; Osawa T; Uemura M; Kimura G; Numakura K; Yamana K; Miyake H; Fukasawa S; Morishima N; Ito H; Uemura H
Int J Urol; 2023 Sep; 30(9):762-771. PubMed ID: 37248753
[TBL] [Abstract] [Full Text] [Related]
19. Caffeic acid phenethyl ester suppresses EGFR/FAK/Akt signaling, migration, and tumor growth of prostate cancer cells.
Tseng JC; Wang BJ; Wang YP; Kuo YY; Chen JK; Hour TC; Kuo LK; Hsiao PJ; Yeh CC; Kao CL; Shih LJ; Chuu CP
Phytomedicine; 2023 Jul; 116():154860. PubMed ID: 37201366
[TBL] [Abstract] [Full Text] [Related]
20. Use of expectant management based on prostate cancer risk and health status: How far are we from a risk-adapted approach?
Spratte BN; Tan HJ; Zambrano IA; Basak RS; Filson CP; Jacobs BL; Hwang S
Urol Oncol; 2023 Jul; 41(7):323.e17-323.e25. PubMed ID: 37149430
[TBL] [Abstract] [Full Text] [Related]
[Next]
